Clinical Trial Update: High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant [NA]

View source ↗

Summary

Clinical trial update on high-dose vitamin A to prevent gastrointestinal graft-versus-host disease in allogeneic hematopoietic stem cell transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Vitamin A (retinol)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Allogeneic Hematopoietic Stem Cell Transplantation Recipient | NA | Status: ACTIVE_NOT_RECRUITING